LY3031207
CAS No. 1381846-21-4
LY3031207 ( LY 3031207 )
Catalog No. M11582 CAS No. 1381846-21-4
A novel potent (IC50=910 ng/mL), highly selective microsomal prostaglandin E synthase 1 inhibitor (mPGES-1) for treatment of undisclosed indications.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
5MG | 873 | Get Quote |
|
50MG | 1782 | Get Quote |
|
100MG | 2250 | Get Quote |
|
200MG | Get Quote | Get Quote |
|
500MG | Get Quote | Get Quote |
|
1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameLY3031207
-
NoteResearch use only, not for human use.
-
Brief DescriptionA novel potent (IC50=910 ng/mL), highly selective microsomal prostaglandin E synthase 1 inhibitor (mPGES-1) for treatment of undisclosed indications.
-
DescriptionA novel potent (IC50=910 ng/mL), highly selective microsomal prostaglandin E synthase 1 inhibitor (mPGES-1) for treatment of undisclosed indications.
-
SynonymsLY 3031207
-
PathwayImmunology/Inflammation
-
TargetPGE synthase
-
RecptorPGE synthase
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1381846-21-4
-
Formula Weight334.80
-
Molecular FormulaC16H19ClN4O2
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO=C(NC1=NC=CN1)C2=CC(CNC(C(C)(C)C)=O)=CC=C2Cl
-
Chemical Name2-chloro-N-(1H-imidazol-2-yl)-5-(pivalamidomethyl)benzamide
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
LY3031207
A novel potent (IC50=910 ng/mL), highly selective microsomal prostaglandin E synthase 1 inhibitor (mPGES-1) for treatment of undisclosed indications.
-
GSK-2894631A
HPGDS inhibitor 2 is a potent, selective hematopoietic prostaglandin D synthase (h-pgds) inhibitor.
-
Crisdesalazine
Crisdesalazine (AAD-2004, AAD2004) is a derivative of aspirin that inhibits microsomal PGE(2) synthase-1 (mPGES-1) activity in response to both LPS-treated BV2 cell with IC50 of 230 nM and recombinant human mPGES-1 protein with IC50 of 249 nM in vitro.